Zydus Lifesciences Ltd
Company Profile
Business description
Zydus Lifesciences Ltd operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products. The product portfolio of the company includes Active Pharmaceutical Ingredients [API] and human formulations. The company's operating segments are: Pharmaceuticals, Consumer Products and Medical Technologies. The majority of revenue is derived from the Pharmaceuticals segment. Geographically, it generates maximum revenue from the United States, followed by India, Europe and other countries.
Contact
Scheme No. 63, Sarkhej-Gandhinagar Highway
Zydus Corporate Park, Survey No. 536
Near Vaishnodevi Circle
Khoraj (Gandhinagar)
AhmedabadGJ382481
INDT: +91 7948040000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
36,827
Stocks News & Analysis
stocks
Lithium’s latest drop and what it means for ASX investors
stocks
Major ASX miner remains overvalued following production update
stocks
Ahead of earnings, is Alphabet stock a buy, a sell, or fairly valued?
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,976.90 | 33.40 | 0.37% |
| CAC 40 | 8,345.51 | 5.40 | 0.06% |
| DAX 40 | 24,902.40 | 55.71 | 0.22% |
| Dow JONES (US) | 51,839.26 | 307.16 | -0.59% |
| FTSE 100 | 10,546.54 | 21.78 | 0.21% |
| HKSE | 25,132.29 | 10.76 | -0.04% |
| NASDAQ | 25,508.07 | 12.17 | -0.05% |
| Nikkei 225 | 66,232.19 | 2,091.07 | 3.26% |
| NZX 50 Index | 13,656.03 | 40.00 | -0.29% |
| S&P 500 | 7,443.28 | 14.41 | -0.19% |
| S&P/ASX 200 | 8,793.30 | 36.30 | 0.41% |
| SSE Composite Index | 3,864.37 | 68.09 | 1.79% |